3SOF

CYTR making new 52 week highs @2.67

CEO of CytRx Subsidiary, RXi Pharmaceuticals, to Participate on RNAi Panel at Mass High Tech BioForum
BusinessWire - January 29, 2007 8:30 AM ET
   

Related Quotes
Symbol   Last Chg
CYTR Trade 2.64 +0.09
Real time quote.
 
CytRx Corporation's (NASDAQ:CYTR) majority-owned subsidiary, Worcester, Massachusetts-based RXi Pharmaceutical Corporation (RXi), today announced that Chief Executive Officer Tod Woolf, Ph.D. will present at the Mass High Tech (MHT) 5th annual BioForum on a panel titled, "RNAi: Talking Outloud About Gene Silencing." Scheduled to join Dr. Woolf on the panel will be senior executives from Alnylam Pharmaceuticals, Inc. and Novartis Institute for BioMedical Research, Inc. Topics covered during the panel discussion will include best practices in RNAi research alliances, future RNAi applications and RNAi's impact on industry and academia.

The 5th annual BioForum is being held Thursday, February 1, 2007 from 5:30 p.m. to 9:00 p.m. in Cambridge, Massachusetts at UK Trade and Investment. For additional information about this conference and/or registration information, please visit http://masshightech.bizjournals.com/masshightech/event/2931.

The Mass High Tech business journal focuses on the business and technology challenges in bringing products and services into the marketplace. More than 67,000 MHT readers each week learn about companies and trends that affect the region before they appear in mainstream business publications and the daily newspapers. MHT focuses on intellectual property protection, access to capital, workforce skills and regulatory issues.

About CytRx Corporation

CytRx Corporation is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics. The Company owns three clinical-stage compounds based on its small molecule "molecular chaperone" co-induction technology. In September 2006 CytRx announced that arimoclomol was shown to be safe and well tolerated at all three doses tested in its Phase IIa clinical trial in patients with ALS. The Company plans to enter a Phase IIb clinical trial with arimoclomol in ALS in the third quarter of 2007, subject to U.S. Food and Drug Administration (FDA) approval. The FDA has granted Fast Track designation and Orphan Drug status to arimoclomol for the treatment of ALS. Also in September 2006, CytRx announced receipt of $24.5 million in a non-dilutive agreement with the privately funded ALS Charitable Remainder Trust to fund continued arimoclomol development for the treatment for ALS in return for a 1% royalty from potential worldwide sales of arimoclomol for the treatment of ALS. The Greater Los Angeles Chapter of The ALS Association is the charitable beneficiary of the ALS Charitable Remainder Trust. For more information on the Company, visit CytRx's Web site at www.cytrx.com.

About RXi Pharmaceuticals Corporation

Massachusetts-based RXi is a biopharmaceutical research and development company that will focus on developing RNAi-based therapeutics for the treatment of human disease. RXi's initial focus will be on neurodegenerative diseases, oncology, type 2 diabetes and obesity. RXi has licenses to a diverse series of early patents and patent applications that were filed from 1998 to 2006 in the areas of RNAi target sequences, RNAi chemistry and RNAi delivery.

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including risks or uncertainties described in CytRx's most recently filed SEC documents, such as its most recent annual report on Form 10-K, all quarterly reports on Form 10-Q and any current reports on Form 8-K filed since the date of the last Form 10-K. All forward-looking statements are based upon information available to CytRx on the date the statements are first published. CytRx undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.

SOURCE: CytRx Corporation

CEOcast, Inc. (for CytRx Corporation)
Dan Schustack, 212-732-4300
[email protected]
< Return to Previous

Surprising 1-Star Stock
CytRx (Nasdaq: CYTR)
30-Day Return   47.4%
One-Year Return   122.4%

52wk Range: 0.87 - 2.83
Volume: 2,796,617
Avg Vol (3m): 1,173,850

Technicals
Last Price Quote is:
17.47%above 13-day MA
39.26%above 50-day MA
RS Rating: 98 

Fundamentals
Key Data:
Market Cap (M): $122.88 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: N/A
Last Analyst Rating: Mkt Outperform

CYTR looks a little over extended now IMO. Sold all @ 3.00. Nice run from 1.31. Will watch for a pullback for re-entry.

nice trade stocks2watch2! CYTR is pulling back this morning.

CYTR closed up 14% yesterday and up another 6% this morning in pre-market.

Trying to get to know CYTR today.
premarket most active under $10
positive net price
volume at least 100,000
So far INET Big Seller moved away
Alert set at 4.25
premarket high of 4.38
waiting for an institutional blessing (Block trade)
INET Big Seller showing up again.
Hmm, I wonder if that's a bluff.
60 and 15 minute charts are positioned for a run
Is it a coincidence that the AX is at the Offer?
I wonder if the AX is reading this because it just showed size.
For real or bluffing - that I don't know.
Is it taking it down to:
4.00
3.60
3.20
That would be a 4 to 1 ratio
If entering at 4 with a stop of 3.90 and an exit of 4.40
Again at 3.60 with a stop of 3.50 and a target of 4
Again at 3.20 with a stop of 3.10 and a target of 3.60
Tempted to play the building method instead of going with consensus.
Tanked
Momentum low: 3.70 (Selling Volume Capitulation?) (Big red volume outside the Bollinger Band)
Touched middle Bollinger Band on the Recovery Rally: 4.00
Price low: 3.93 (Small red volume inside the Bollinger Band)
Are we going to get big volume when it breaks the Upper Bollinger Band?
Takuri at Hourly Chart with a high of: 4.10
The Squeeze at the minute chart.
False breakout, will it be followed by a real one.
INET Big Seller sitting at High of Takuri.
Would someone big take that offer?
Lots of traders must be holding their bladders right now.
Daily volume higher than yesterday already
The minute chart looks like Trader Vic's 2B.
Tanked again with a higher low this time so far.
Saw a white block(I don't know if that's a buy or a sell)
Does anyone know what it means when a market maker flicker level 2?

I would like to follow up on CYTR today.
pre market most active
positive net price (open above the the doji too)
volume at least 100,000
saw a block trade
nice level 2 set up
previous hour's high = 4.29
premarket high = 4.50
Is it a coincidence that 4.50 is 0.25 above the open?
Caught a ride with the block trade at 4.25 (didn't wait for 25 cents above the open anymore)
Once the trigger is hit, where would be the next resistance after 4.50 be?
Will the Market Makers gun 4.50?
I'm thinking if I should have sold at 4.49 since 4.50 is resistance but if another block trade bought at that price - my reasoning is, that buyer must want to make more.
Unless, that "buyer" was actually a seller selling at the ask.
The Market makers may not gun it but what if retail investors like what they see and buy at the same time...
Will we get the added bonus of a short squeeze?
This may still go up but I'm out at 4.84 (3:46pmET)
Good luck long term holders!

This is how the latest chart looks like for long term holders.

In again at CYTR at 4.95
This time because the AX seemed to have given way
Has it lost momentum already?
Hourly chart and 15 minute chart still showing a positive trend, so far.
The 15 minute chart just made a higher high.
Where's the next resistance?
Maybe time for those few brave shorts to cover?
Just made a new high on the 15 minute chart again.
Some of those market makers are trying to stop this stock from flying by showing size.
Will the demand be stopped so soon?
One of the market maker's tactics is to show size at the ask and swallow weak hands at the bid.
Are they using it here?
Trading range:
High: $5.49
Mid:   $5.37
Low:  $5.25
Trading Range just got smaller:
High: $5.40
Low: $5.31
Scalpers must be really working right now.
It's good to respect the message that the Market Makers are sending
Got out at $5.47 (0.01 below the AX) at the 3rd green candle(at thtat time) of the 15 minute chart when the 1 minute chart closed below the 8 ma.
Waiting to get in again if a momentum low happens.
The momentum low I'm waiting for is a huge volume at the end of the move when a stock tanks outside the B- of a 1 minute Bollinger Band.
My mental stop would be 10 cents with a target of at least 25 cents profit.

Looking at the most recent chart (stockcharts is delayed - I'm referring to real time chart)
Volume is higher than previous day's already.
Would it close as a shooting star or would it close strong?

Previous hour' high = $ 5.16
Previous hour's low = $4.95
Looks like we have an hourly doji pivot point.
would the risk: reward be worth getting in at 5.16?
If the stop is at $4.94 and the target being $5.49?
How much support is underneath and how much resistance is on top?
I have a tendency to choose the path of least resistance.
Hourly chart created a higher high and the 15 minute chart closed above the 8 ma - a signal for swing traders?
Another set of traders that could jump in are those following the 8ma.
So far, it opened above the 15 minute 8ma but will it close above it - we shall see.
Still has a nice level 2 set up so far.
closed below the 15 minute 8 ma but volume on the hourly chart is higher than the previous hour's as it made a higher high

I have my alert set at 4.11
Looking at $4.10 as support.
Let's see if it will be taken there.

9:41am ET low= $4.56 with volume that did not stand out from the previous minute. Had a reaction rally though at $4.85

10:25am ET low = $4.46 Huge volume outside the B- following the previous tank.

11:04am ET false breakdown (price pierced lower Bollinger Band with low volume)

11:07am ET low = $4.48 Huge volume relative to false breakdown.

momentum low: $4.48(11:07am ET)
Reaction Rally: $4.55 (touched or exceeded BB)
Price low:$4.51(low inside Bollinger Band with low volume)

Entry:
momentum low at: $4.48
Higher High at:$4.5201
previous high at: $4.50

Bid at previous high: $4.50
mental stop at: $4.40

Looking at 4.85 as resistance to be broken.
Went as high as 4.83
second attempt failed to make a higher high
1 minute chart opened and closed below 8
Out at $4.81

History seems to be repeating itself here at  CYTR
In at:4.56

mental stop at 4.46

next buy target: 4.10

Out at 4.60

I want to concentrate more on CNLG

I was supposed to take a break already after CNLG's trade but while I was click,clicking - I saw an opportunity at CYTR.
CYTR went very close to my buy point.
Buy point= 4.10
Low of the day = 4.11
I still had to wait for confirmation of strength though.
When it made a higher high at 4.16, I jumped in at 4.14 with a mental stop of 4.04
Looks like blocks are coming back in.
A short squeeze would be really nice to see in here.
I missed that 4.47 spike. It bounced off the 200 ma of the hourly chart.
I'm out at 4.36
This may go up from here.
It's just there's nothing happening much right now.
CNLG looks like it's in the process of tanking.
I'll go there for now.

In at 4.49
It really does make a difference when you're focused on only one stock at a time.
Missing out on the time and sales prints could cost us a lot.
I have to pick up my son from school now.
I'm out at 4.57
Good luck to all.

CYTR starting to look interesting again.